New draft guidance from the FDA is intended to clarify how the agency evaluates real world data (RWD) to determine whether they are of sufficient quality to produce real world evidence (RWE) that can be used when the agency makes regulatory decisions about medical devices. The draft guidance, “Use of Real-World Evidence To Support Regulatory Decision-Making for Medical Device... Read More